|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Fortaz (ceftazidime) Injection, Fortaz (ceftazidime sodium) Injection, Ceptaz (ceftazidime) Injection (L-arginine formulation), GlaxoSmithKline NDA 50-578/S-040, 50-634/S-012 & 50-646/S14 3/29/02 4/8/02 3/29/02
Fortaz (ceftazidime sodium) Injection Fortaz (ceftazidime) Injection, GlaxoSmithKline NDA 50-578/S-042 & 50-634/S-014 CEFTAZIDIME Injection 1GM/VIAL TAZICEF Abbott 064032 CEFTAZIDIME Injection 1GM/VIAL TAZICEF Abbott 064032 CEFTAZIDIME Injection 2GM/VIAL TAZICEF Abbott 062662 CEFTAZIDIME Injection 2GM/VIAL TAZICEF Abbott 062662 CEFTAZIDIME Injection 500MG/VIAL TAZICEF Abbott 062662 CEFTAZIDIME Injection 6GM/VIAL TAZICEF Abbott 050578 CEFTAZIDIME Injection 1GM/VIAL FORTAZ GLAXOSMITHKLINE
050578 CEFTAZIDIME Injection 2GM/VIAL FORTAZ GLAXOSMITHKLINE
050578 CEFTAZIDIME Injection 500MG/VIAL FORTAZ GLAXOSMITHKLINE
050578 CEFTAZIDIME Injection 6GM/VIAL FORTAZ GLAXOSMITHKLINE
062640 CEFTAZIDIME Injection 1GM/VIAL TAZIDIME LILLY
062655 CEFTAZIDIME Injection 1GM/VIAL TAZIDIME LILLY
062655 CEFTAZIDIME Injection 2GM/VIAL TAZIDIME LILLY
062640 CEFTAZIDIME Injection 2GM/VIAL TAZIDIME LILLY
062640 CEFTAZIDIME Injection 500MG/VIAL TAZIDIME LILLY
050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 10GM/VIAL CEPTAZ GLAXOSMITHKLINE
050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 1GM/VIAL CEPTAZ GLAXOSMITHKLINE
050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 2GM/VIAL CEPTAZ GLAXOSMITHKLINE
063221 CEFTAZIDIME SODIUM Injection 10MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER Baxter 063221 CEFTAZIDIME SODIUM Injection 20MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER Baxter 063221 CEFTAZIDIME SODIUM Injection 40MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER Baxter | 050634 CEFTAZIDIME SODIUM Injection 20MG BASE/ML FORTAZ IN PLASTIC CONTAINER GLAXOSMITHKLINE |
050634 CEFTAZIDIME SODIUM Injection 40MG BASE/ML FORTAZ IN PLASTIC CONTAINER GLAXOSMITHKLINE |
Fortaz (ceftazidime for injection), Glaxo Group Limited |
Fortaz (ceftazidime sodium injection), Glaxo Group Limited | FORTAZ (ceftazidime) Injectable, GlaxoSmithKline, Labeling Revision | FORTAZ (ceftazidime) Injection, GlaxoSmithKline, Labeling Revision
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|